ME&MGopen digital biomarkers help track Generalized Myasthenia Gravis symptoms

        

At the WMS Congress in October 2025 in Vienna, Austria, we presented our ME&MGopen™ app, developed to better understand generalized myasthenia gravis (gMG). The app uses digital biomarkers and standard clinical questionnaires completed at home to assess symptom manifestation in real-life conditions.

Share